why choose us

300×250 Ad Slot

Drug FDA Status

Showing 10 of 158 result(s) (Page 1 of 16)
Drug Name: Lifyorli

Active Ingredient: relacorilant

Approval Date: 2026-03-25

Description: To treat platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer after one to three prior systemic treatment regimens, at least one of which included bevacizumab

Drug Name: Avlayah

Active Ingredient: tividenofusp alfa-eknm

Approval Date: 2026-03-24

Description: To treat certain individuals with Hunter syndrome (Mucopolysaccharidosis type II or MPS II)

Drug Name: Lynavoy

Active Ingredient: linerixibat

Approval Date: 2026-03-17

Description: To treat cholestatic pruritus associated with primary biliary cholangitis

Drug Name: Icotyde

Active Ingredient: icotrokinra

Approval Date: 2026-03-17

Description: To treat moderate-to-severe plaque psoriasis in patients 12 years and older who weigh at least 40 kg and who are candidates for systemic therapy or phototherapy

Drug Name: Yuviwel

Active Ingredient: navepegritide

Approval Date: 2026-02-27

Description: To increase linear growth in pediatric patients 2 years and older with achondroplasia with open epiphyses

Drug Name: Loargys

Active Ingredient: pegzilarginase-nbln

Approval Date: 2026-02-23

Description: To treat hyperarginemia in adults and pediatric patients two years and older with Arginase 1 Deficiency, in conjunction with dietary protein restriction

Drug Name: Bysanti

Active Ingredient: milsaperidone

Approval Date: 2026-02-20

Description: To treat schizophrenia and to treat manic or mixed episodes associated with bipolar I disorder

Drug Name: Adquey

Active Ingredient: difamilast

Approval Date: 2026-02-12

Description: To treat mild to moderate atopic dermatitis

Drug Name: Zycubo

Active Ingredient: copper histidinate

Approval Date: 2026-01-12

Description: To treat Menkes disease

Drug Name: Myqorzo

Active Ingredient: aficamten

Approval Date: 2025-12-19

Description: To treat symptomatic obstructive hypertrophic cardiomyopathy

300×250 Ad Slot